Manipal Health IPO Lists at ₹593: Marginal Gain Amidst Mixed Expert Views

Manipal Health Enterprises IPO listed today at ₹593 per share, marking a marginal 0.51% premium over its ₹590 IPO price. The listing occurred on August 5, 2026, at 10:00 IST on both BSE and NSE.

• Estimated Listing Price: ₹593 per share
• IPO Price: ₹590 per share
• Premium: 0.51%
• Overall Subscription: 4.92 times
• QIB Subscription: 8.25 times
• NII Subscription: 1.02 times
• RII Subscription: 93%
• IPO Price Band: ₹560-590 per share
• Company Valuation (Upper End): Over ₹77,600 crore

This modest premium materialized despite a pessimistic Grey Market Premium (GMP) of +3. The GMP had earlier seen significant fluctuation, ranging from ₹-15 to ₹35 across the preceding 12 sessions.

Analyst Perspectives Diverge

Expert opinions on Manipal Health Enterprises’ listing prospects were notably varied. Mahesh M. Ojha of Kantilal Chhaganlal Securities highlighted the company’s high valuation and weaker operating metrics compared to peers.

• Mahesh M. Ojha (Kantilal Chhaganlal Securities): Noted high valuation (FY26 P/E of 85.67x) and weaker operating metrics like lower bed occupancy and declining return on capital employed (ROCE). He predicted a flat-to-discount listing, advising profit-booking for existing investors and a wait for new investors.
• Tushar Badjate (Badjate Stock & Shares): Emphasized the long-term growth potential of India’s healthcare sector due to increasing incomes, insurance penetration, and an aging population. He suggested Manipal Health is well-positioned, despite its premium valuation.
• Darshan Rathod (Multyfi): Advised investors to maintain realistic expectations for listing gains. He stated that the IPO pricing already incorporates a substantial portion of the company’s future growth and encouraged a focus on long-term prospects.

IPO Structure and Fund Allocation

The IPO consisted of a fresh issue of up to ₹8,000 crore in equity shares, alongside an Offer for Sale (OFS) of up to 2.16 crore equity shares from existing shareholders. Manipal Health Enterprises, a Bengaluru-based hospital chain, outlined specific uses for the fresh issue proceeds.

• ₹5,378 crore: To repay or prepay borrowings of its subsidiary, Manipal Hospitals Pvt. Ltd.
• ₹574 crore: Allocated for acquiring a minority stake in its step-down subsidiary, Sahyadri Hospitals Pvt. Ltd.
• Remaining funds: Designated for general corporate purposes.

The IPO was managed by a consortium of book-running lead managers, including Kotak Mahindra Capital Company, Axis Capital, Goldman Sachs (India) Securities, Jefferies India, J.P. Morgan India, UBS Securities India, and DBS Bank India. KFin Technologies served as the registrar for the offering.